University college

Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024

Retrieved on: 
Tuesday, April 9, 2024
Neurology, University college, Patient, McGill University Health Centre, Head, Doctor of Philosophy, MDCM, OPMD, Otorhinolaryngology, Natural history

To register, click here .

Key Points: 
  • To register, click here .
  • The event will feature two key opinion leaders who will discuss the clinical symptoms and the natural history of oculopharyngeal muscular dystrophy (OPMD), a rare genetic muscle disorder.
  • The key opinion leaders will also review the clinical and radiographic methods employed to evaluate disease progression and discuss the current treatment landscape for patients diagnosed with OPMD.
  • A live question and answer session will follow the formal presentations.

Willis Lease Finance Corporation Welcomes Colm Barrington to its Board of Directors

Retrieved on: 
Friday, April 5, 2024
Tax, Growth, Aer Lingus, University college, Part, Knowledge, GE Capital Aviation Services, COVID-19, FBO, Sale, Aviation, Acquisition, FLY Leasing, Security (finance), BBAM, University College Dublin, Babcock & Brown, GECAS, Aircraft, WLFC, Economics, Guinness Peat Aviation, Airline

COCONUT CREEK, Fla., April 05, 2024 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC”), the leading lessor of commercial aircraft engines and global provider of aviation services, is pleased to announce the appointment of Colm Barrington to its Board of Directors (“the Board”) effective April 1, 2024.

Key Points: 
  • COCONUT CREEK, Fla., April 05, 2024 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC”), the leading lessor of commercial aircraft engines and global provider of aviation services, is pleased to announce the appointment of Colm Barrington to its Board of Directors (“the Board”) effective April 1, 2024.
  • Mr. Barrington left his role at GECAS soon after to start his own aircraft lease management company, which later merged into Babcock & Brown Limited.
  • "We are delighted to announce the addition of Colm to our Board of Directors," stated Charles F. Willis, Founder and Executive Chairman of WLFC.
  • Willis Lease Finance Corporation (“WLFC”) leases large and regional spare commercial aircraft engines, auxiliary power units and aircraft to airlines, aircraft engine manufacturers and maintenance, repair, and overhaul providers worldwide.

BioAge Appoints Renowned Cardiologist and Biopharma Entrepreneur Michael H. Davidson, MD, to its Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
Research, FDA, Genetics, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Science, Internal medicine, Incretin, Obesity, AstraZeneca, Novo Nordisk, Cardiology, University college, Patient, DSM-IV codes, Weight loss, NAMS, Doctor of Philosophy, MD, Biology, PPD, Inc., Book, Ageing, Pharmaceutical industry

BioAge Labs, Inc., ("BioAge"), a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases by harnessing the biology of aging, today announced the appointment of Michael Davidson, MD to the company's board of directors.

Key Points: 
  • BioAge Labs, Inc., ("BioAge"), a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases by harnessing the biology of aging, today announced the appointment of Michael Davidson, MD to the company's board of directors.
  • "We are delighted to welcome Michael to BioAge's board of directors," said Kristen Fortney, PhD, CEO and co-founder of BioAge Labs.
  • "I'm excited to join the board of BioAge at this pivotal juncture, as the company progresses azelaprag into Phase 2 trials in obesity," said Davidson.
  • I look forward to working with the team to bring this promising therapy to patients in need."

Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®

Retrieved on: 
Friday, March 15, 2024
Pharmacology, Toxicity, Protein corona, Brain, Plasma, Longevity, Multiple sclerosis, BBB, ALS, CNM, University college, Medicine, Gastrointestinal tract, Research, Gold, Blood, Traffic barrier, Radiology, Protein, Clinical trial, CSO, Neurodegenerative disease, Apolipoprotein, Research fellow, Copper

Simultaneously, the depletion of opsonin-based proteins in the corona extends their circulation time in the blood, as observed clinically.

Key Points: 
  • Simultaneously, the depletion of opsonin-based proteins in the corona extends their circulation time in the blood, as observed clinically.
  • “When we invented the electro-crystal-chemical method to grow clean-surfaced, highly faceted gold nanocrystals, we certainly had catalytic optimization in mind.
  • However, we also understood that the protein corona can control the location of our nanocrystals in vivo.
  • A Phase 3 registrational clinical trial of CNM-Au8 for the treatment of the progressive neurodegenerative disease, amyotrophic lateral sclerosis, is presently planned to launch in 2024.

Experts to examine how Supreme Court Affirmative Action decision impacts legal and medical education at upcoming University of Houston event

Retrieved on: 
Wednesday, April 3, 2024
Constitution, Internal medicine, Tilman, Professional development, SFFA, University, Harvard University, Nature, Associate professor, DEI, Inclusion, Equal Protection Clause, Dean (education), University college, Family medicine, Virginia School for Girls, Diversity, Environmental studies, Law School Admission Council, Supreme court, Operation, MPP, University of Houston, MCLE, College of Medicine, Associate, Community health, Student, Community engagement, Supreme, Law Center, Medical school, McGovern Medical School, Psychiatry, Assistant, Behavioural sciences, LSAC, Baylor College of Medicine, CME, Management

"In SFFA v. Harvard, the U.S. Supreme Court found that the race-conscious admission policies of Harvard University and the University of North Carolina violated the Equal Protection Clause of the U.S. Constitution," said UH Law Center Dean Leonard Baynes.

Key Points: 
  • "In SFFA v. Harvard, the U.S. Supreme Court found that the race-conscious admission policies of Harvard University and the University of North Carolina violated the Equal Protection Clause of the U.S. Constitution," said UH Law Center Dean Leonard Baynes.
  • "The Supreme Court decisions on affirmative action have reshaped the landscape at medical schools across the country," said Dr. Stephen Spann, founding dean of the Fertitta Family College of Medicine.
  • "It is important to understand the impacts, so our students continue receiving the best health care education and our clinicians continue providing quality health care services to the community."
  • Attending healthcare and legal professionals will earn 6 hours of Texas MCLE credit or 6.25 CME credits, respectively.

Interfor Appoints Christina Sistrunk to its Board of Directors

Retrieved on: 
Wednesday, March 6, 2024
Advisory board, Woman, TSX, Ohio State University, University college, Chemical engineering, Shell, Aera Energy, Management

BURNABY, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) is pleased to announce the appointment of Christina Sistrunk of Lumberton, Mississippi as an independent director of the Company.

Key Points: 
  • BURNABY, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) is pleased to announce the appointment of Christina Sistrunk of Lumberton, Mississippi as an independent director of the Company.
  • Ms. Sistrunk served as President and CEO of Aera Energy, LLC (an independent upstream oil and gas company) between 2015 and 2020.
  • Ms. Sistrunk currently serves on the External Advisory Council for The Ohio State University College of Engineering, and on the Advisory Board for Renewell Energy.
  • Her appointment increases the percentage of women directors on Interfor’s Board, to 30%.

NYC Oral Surgeon, Dr. Mark Stein, named to the 2024 Super Doctors® list!

Retrieved on: 
Monday, February 26, 2024
MD, Physician, Mount Sinai Beth Israel, University college, Dental implant, Super, University, Oral and maxillofacial surgery, Staten Island University Hospital, Patient, Dentistry, Publication, Research

New York, New York, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mark Stein, DDS, MD has been named to the Super Doctors® list, a special advertising section in the 2024 issue of The New York Times Magazine.

Key Points: 
  • New York, New York, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mark Stein, DDS, MD has been named to the Super Doctors® list, a special advertising section in the 2024 issue of The New York Times Magazine.
  • Only 5% of New York’s oral surgeons are selected for the Super Doctors list.
  • The highest-scoring nominees are then named among the top 5% of candidates and chosen for the Super Doctors list.
  • To learn more about undergoing oral surgery with Dr. Mark Stein , you can contact New York Oral & Maxillofacial Surgery by phone at (212) 888-4760 or by requesting an appointment online .

Summer Consultants Announces Addition of Architect Heather Casey and Interior Designer Katie Gardner

Retrieved on: 
Wednesday, February 21, 2024
Architecture, Lerner Enterprises, GSA, Summer, Education, NCIDQ, George Mason University, Virginia Commonwealth University, Consultant, VCU, NAVFAC, Government, University college, AIA, IDIQ, Safeway

McLean, VA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Summer Consultants, an award-winning engineering firm, is excited to announce the appointment of Heather Casey, AIA, as senior architect and Katie Gardner, NCIDQ, as interior designer.

Key Points: 
  • McLean, VA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Summer Consultants, an award-winning engineering firm, is excited to announce the appointment of Heather Casey, AIA, as senior architect and Katie Gardner, NCIDQ, as interior designer.
  • They will also assist with small IDIQ contracts that a growing number of Summer Consultants’ clients are using.
  • "We are thrilled to welcome Heather Casey and Katie Gardner, who will expand our breadth of expertise," said James Hoffman, President of Summer Consultants.
  • Heather Casey brings over 25 years of experience and expertise to her role as senior architect, having previously worked at MTFA Architecture.

Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System

Retrieved on: 
Friday, March 8, 2024
Biotechnology, Surgery, Public Relations, Investor Relations, Health, FDA, Medical Devices, Communications, Health Technology, Engineering, Multimedia, Medical director, Physician, Food, University college, Safety, Food and Drug Administration, Patient, Head, Medical device

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel CellFX nsPFA Percutaneous Electrode System for use in the ablation of soft tissue in percutaneous and intraoperative surgical procedures.

Key Points: 
  • Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel CellFX nsPFA Percutaneous Electrode System for use in the ablation of soft tissue in percutaneous and intraoperative surgical procedures.
  • View the full release here: https://www.businesswire.com/news/home/20240307706065/en/
    CellFX nsPFA Percutaneous Electrode System (Source: Pulse Biosciences, Inc.)
    “The FDA clearance of our Percutaneous Electrode System is the initial major milestone for Pulse Biosciences in surgery.
  • This percutaneous electrode is designed for non-cardiac applications.
  • “The CellFX nsPFA Percutaneous Electrode System represents a much needed and promising new minimally invasive nonthermal treatment option for patients.

The Inner Circle Acknowledges, Lauren A. Stevenot, DDS as a Pinnacle Lifetime Member

Retrieved on: 
Monday, February 26, 2024
Private practice, RAF Lakenheath, DDS, Ohio Dental Association, Orthodontics, Inner circle, Air force, Multimedia, American Dental Association, Education, Tennis, Skiing, Military personnel, Dental surgery, Dental care, University college, Communication, Family, Crown, Health, Infant, Patient, Knowledge, Marquette University, The, Travel, Carroll High School, Dentistry

CINCINNATI, Feb. 26, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Lauren A. Stevenot, DDS is acknowledged as a Pinnacle Lifetime Member for her contributions to the Dentistry field.

Key Points: 
  • CINCINNATI, Feb. 26, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Lauren A. Stevenot, DDS is acknowledged as a Pinnacle Lifetime Member for her contributions to the Dentistry field.
  • She serves as an integral part of Reading Family Dental, a trusted family practice where she works alongside her uncle, Dr. Alan Laub, DDS.
  • Her brother, Dr. Ryan Dull, DDS, is currently serving in the U.S. Navy as a dentist.
  • She looks forward to serving the Reading community for years to come and continuing her journey of excellence in dentistry.